In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
Jessica Ritsick, Yifan Wang, Ph.D. Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results